Investigating the Synergistic Role of IL-1β and TGF-β in Endothelial-to- Mesenchymal Transition during Coronary Artery Disease
JSHS · 2025
Overview
The endothelium, a layer of cells lining the inner wall of coronary arteries, contributes to blood hemostasis and healthy function of the heart. In coronary artery disease (CAD), endothelial cells (ECs) acquire changes in their functions in a process calle d endothelial -to-mesenchymal transition (EndMT). EndMT is a multi -stage phenotypic change by which ECs become pro - migratory, pro-proliferative, and profibrotic, contributing to plaque formation and arterial occlusion. It is understood that the cytokines in terleukin-1 beta (IL-1β) and transforming growth factor beta (TGFβ) influence the progression of EndMT, but their specific roles are still not fully understood. We hypothesize that IL -1β and TGFβ uniquely impact endothelial cells and develop atherosclerotic plaques, and hope to identify potential biomarkers and therapeutic targets for developing new treatments. In this project, human aortic ECs were stimulated with IL-1β, TGFβ, or both for 72 hours. Relevant EndMT markers were assessed by western blotting for protein expression, qRT -PCR for gene expression, and immunocytochemistry. It was found that IL -1β alone induces partial EndMT, upregulating inflammatory markers like IRAK1, IRAK4, and ICAM -1. This indicates its role in early vascular remodeling in CAD. TGFβ alone upregulates smooth muscle actin (SMA) and downregulates CD31, prom oting mesenchymal transition and fibrosis. Together, IL-1β and TGFβ enhance mesenchymal markers (Vimentin, SNAIL1) and suppress endothelial markers (VE -Cadherin, eNOS), accelerating disease progression. IL-1β and TGFβ play distinct yet synergistic roles in promoting EndMT, with IL -1β driving inflammation and TGFβ inducing fibrosis. Targeting these pathways offers therapeutic strategies to slow or prevent CAD progression by mitigating EndMT and vascular remodeling.
Competition history
- JSHS 2025
Resources
Related projects
ISEF · 2025
Investigating the Synergistic Role of IL-1BETA and TGF-BETA in Endothelial-to- Mesenchymal Transition in Coronary Artery Disease
ISEF · 2015
Contact Dependency of Immune Cells and Endothelial Cells in Promoting Angiogenesis
ISEF · 2025
Possible Role of VEGF-B/VEGF-A Relationship in Ischemic Coronary Artery Disease
ISEF · 2021
Assessing the Expression of Angiogenesis-Related Receptors in Endothelial Cell RNA
ISEF · 2016
mTOR Regulates the Phenotypic Modulation of De-differentiated Mesenchymal Stem Cells in Vascular Disease
ISEF · 2022
BMP4 Prevents Thrombin Induced Inflammation and Vascular Damage in Endothelial Cells
ISEF · 2019
ETM* Is Indispensable to Endothelial Cell Physiology during Pathological Angiogenesis
ISEF · 2026
The Role of VEGF and FGF21 in Restoring the Hypotrophic Response of Endostatin in Neonatal Rat Ventricular Myocytes
Closest projects by meaning, across every fair and year in the corpus.